214 related articles for article (PubMed ID: 38084139)
21. Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.
Zhang J; Wang Y; Ma J; Aimudula A
Front Oncol; 2023; 13():1163714. PubMed ID: 37483501
[TBL] [Abstract][Full Text] [Related]
22. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway.
Na J; Zhou W; Yin M; Hu Y; Ma X
Tissue Cell; 2022 Jun; 76():101795. PubMed ID: 35413491
[TBL] [Abstract][Full Text] [Related]
23. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
[TBL] [Abstract][Full Text] [Related]
24. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma.
Wang W; Cui G; Zhao S
Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013
[TBL] [Abstract][Full Text] [Related]
25. Transcription factor NFIC functions as a tumor suppressor in lung squamous cell carcinoma progression by modulating lncRNA CASC2.
Zhang H; Luo Z; Tang J; Tian J; Xiao Y; Sun C; Wang T
Cell Cycle; 2022 Jan; 21(1):63-73. PubMed ID: 34985387
[TBL] [Abstract][Full Text] [Related]
26. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma.
Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H
Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224
[TBL] [Abstract][Full Text] [Related]
27. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
Lu Y
Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs RP5-821D11.7, APCDD1L-AS1 and RP11-277P12.9 were associated with the prognosis of lung squamous cell carcinoma.
Luo Y; Xuan Z; Zhu X; Zhan P; Wang Z
Mol Med Rep; 2018 May; 17(5):7238-7248. PubMed ID: 29568882
[TBL] [Abstract][Full Text] [Related]
29. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.
Lei K; Liang R; Tan B; Li L; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
Oxid Med Cell Longev; 2023; 2023():6811625. PubMed ID: 36703911
[TBL] [Abstract][Full Text] [Related]
30. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
Ke D; Guo Q; Fan TY; Xiao X
Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
[No Abstract] [Full Text] [Related]
32. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
[TBL] [Abstract][Full Text] [Related]
33. Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression.
Zhao Z; Li H; Li J; Rong Y; Zhao L; Hao M; Tian F
J Cardiothorac Surg; 2024 Apr; 19(1):222. PubMed ID: 38627774
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
[TBL] [Abstract][Full Text] [Related]
35. Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma.
Weng C; Wang L; Liu G; Guan M; Lu L
Front Oncol; 2021; 11():763027. PubMed ID: 34868980
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma.
Wang XJ; Chen JP; Qiao XW; Meng WY; Wang YW; Meng YC; Zhao R; Lin W; Liao YD; Xiao H; Mei PY
Curr Med Sci; 2024 Apr; 44(2):309-327. PubMed ID: 38517673
[TBL] [Abstract][Full Text] [Related]
37. Protocadherin alpha 3 inhibits lung squamous cell carcinoma metastasis and epithelial-mesenchymal transition.
Tao Y; Fei L; Chang L; Yongyu L; Jianhui J; Yanan L; Yi R
Genes Genomics; 2022 Feb; 44(2):211-218. PubMed ID: 34086268
[TBL] [Abstract][Full Text] [Related]
38. Construction of a prognostic model for lung squamous cell carcinoma based on immune-related genes.
Pu J; Teng Z; Yang W; Zhu P; Zhang T; Zhang D; Wang B; Hu Z; Song Q
Carcinogenesis; 2023 May; 44(2):143-152. PubMed ID: 36455238
[TBL] [Abstract][Full Text] [Related]
39. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m
Li Y; Li X; Deng M; Ye C; Peng Y; Lu Y
Oxid Med Cell Longev; 2022; 2022():4320809. PubMed ID: 36246404
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a prognosis prediction model for lung squamous cell carcinoma related to PET/CT: basing on immunogenic cell death-related lncRNA.
Han Y; Dong Z; Xing Y; Zhan Y; Zou J; Wang X
BMC Pulm Med; 2023 Dec; 23(1):511. PubMed ID: 38102594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
